Freedom of Information Request – Ref: FOI 142-2025
Thank you for your recent Freedom of Information request. Please find our response below.
You asked:
1. The number of young people on your waiting list for a first appointment (assessment) as of the date of this email or nearest available.
Our response:
262
You asked:
2: The average length of time young people are currently waiting between referral and first appointment (assessment)
Our response:
34 days
You asked:
3: The average length of time young people are currently waiting between initial referral and first therapeutic intervention.
Our response:
There is currently no national defined standard for what constitutes “treatment” and not all services are structured to initiate treatment at the second contact
You asked:
4: How many young people assessed were not offered follow up treatment at CAMHS in the year 2024-25, as a number and a proportion of the total of young people assessed?
Our response:
– Number of people assessed who were not offered follow-up treatment at CAMHS in the year 2024/25 – 1326
– Proportion of people assessed who were not offered follow-up treatment at CAMHS in the year 2024/25 – 42%
You asked:
5: The longest time any young person has been on your current waiting list (as of the date of the receipt of this email or nearest)
Our response:
126 days
You asked:
6: The average wait between referral and assessment for neurodevelopmental/neurodiverse conditions on the date of this request or nearest available data.
Our response:
494.4 days
You asked:
7: The number of young people on the waiting list for neurodevelopmental/neurodiverse assessments on the date of this request or nearest available data.
Our response:
4276
Note: In response to questions 6 and 7 of this Freedom of Information request, we have provided the average waiting time for assessments and the number of people currently on the assessment waiting list (i.e. those awaiting first contact).
- Patients genuinely awaiting their first neurodevelopmental assessment, and
- Patients who have transferred from Gloucestershire Community Paediatrics, specifically those on ongoing ADHD medication management
As part of a newly agreed pathway, Gloucestershire Community Paediatrics has transferred responsibility for ADHD medication patients to the GHC Neurodevelopmental Assessment Team.
Consequently, these cohorts have been amalgamated within the reported waiting list figures. This means that the waiting list position should be understood as a combined figure rather than a reflection solely of new assessment demand.
Next steps:
Should you have any queries in relation to our response, please do not hesitate to contact us. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:
Louise Moss
Head of Legal Services / Associate Director of Corporate Governance
c/o Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth, GL3 4AW
E-mail: louise.moss@ghc.nhs.uk
If you are not content with the outcome of any review, you may apply directly to the Information Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.